Ultrahypofractionation of localized prostate cancer Frank WolfFelix SedlmayerThomas Wiegel Review Article Open access 10 December 2020 Pages: 89 - 96
Effectiveness of rectal displacement devices in managing prostate motion: a systematic review Mahdieh Afkhami ArdekaniHamed GhaffariSoheila Refahi Review Article 22 May 2020 Pages: 97 - 115
The Prostate Cancer Outcomes (PCO) study in prostate cancer centres certified by the German Cancer Society Christoph KowalskiGünther CarlSimone Wesselmann Short Communication 16 June 2020 Pages: 116 - 117
Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects Matthias MollChristopher PaschenGregor Goldner Original Article Open access 08 July 2020 Pages: 118 - 123
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis Jörg TamihardjaMax SchortmannBülent Polat Original Article Open access 24 August 2020 Pages: 124 - 132
Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity Ciro FranzeseMarco BadalamentiMarta Scorsetti Original Article 01 October 2020 Pages: 133 - 140
EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial–mesenchymal transition Qiang ZhenYaxiao ZhangJiabao Liu Original Article 17 July 2020 Pages: 141 - 149
Performance assessment of two motion management systems for frameless stereotactic radiosurgery Hao WangZhiyong XuKe Nie Original Article Open access 12 October 2020 Pages: 150 - 157
Correction to: Managing patient flows in radiation oncology during the COVID-19 pandemic Dennis Akuamoa-BoatengSimone WegenSimone Marnitz Correction Open access 15 December 2020 Pages: 158 - 158
Sichere Schwangerschaft nach Brustkrebstherapie von BRCA-Mutations-Trägerinnen? Rainer Souchon Literatur kommentiert 11 December 2020 Pages: 159 - 161
Abnehmende Morbidität und Letalität bei Kindern nach Behandlung einer akuten lymphoblastischen Leukämie: ein Bericht der Childhood Cancer Survivor Study Martin G. Sauer Literatur kommentiert Open access 11 December 2020 Pages: 162 - 163
Das ereignisfreie Überleben als Endpunkt, der unter anderem den PSA-Verlauf einbezieht, ist kein Surrogat für das Gesamtüberleben nach Strahlenbehandlung eines lokalisierten Prostatakarzinoms Carsten Nieder Literatur kommentiert 26 November 2020 Pages: 164 - 165